Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes Review

cited authors

  • Pratley, Richard E.

authors

Publication Date

  • February 1, 2009

webpage

published in

category

keywords

  • alogliptin
  • dipeptidyl peptidase-4
  • glucagon-like peptide-1
  • incretin
  • type 2 diabetes

start page

  • 503

end page

  • 512

volume

  • 10

issue

  • 3